Zimbabwe has declined a major US health deal valued at 367 million US dollars (£272m) over five years due to the United States' request for sensitive information.
This rejection was revealed after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesperson later clarified that the United States was requesting health data for research and commercial purposes but was unwilling to share the benefits from any future medical innovations.
"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for continued dialogue to secure a deal agreeable to both sides so the country's vital HIV programme can be sustained.
Wider Implications
Zimbabwe's decision comes after a comparable situation in Kenya, where a court suspended a similar deal with the US after concerns were raised about the safety of Kenyans' medical information.
After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the US government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance openness and responsibility.
As per statements, 16 African countries have so far agreed to similar agreements, representing over $18.3bn in new funding.
Details of the Declined Agreement
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to provide its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that might be developed from that shared data," he stated.
"Effectively, our nation would supply the raw materials for medical research without any assurance that the final treatments would be accessible to our population if a new health crisis emerge."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting structures previously set up through the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This mechanism is designed to guarantee that when a nation contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "are not meant as opposition to America," he added.
"We are open to continued dialogue with our American counterparts on how subsequent collaboration could be structured in a manner that respects the sovereignty and dignity of each country."
Medical Community Response
Medical experts expressed it acknowledged the official position, but urged that negotiations should continue given that a large portion of the country's Aids initiatives depended on international support.
"Where specific concerns exist, such as those relating to information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," it added.
This impasse highlights the ongoing challenges between receiving much-needed foreign assistance and protecting local interests in an ever more data-driven world.